Welcome to GTx, a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions.

Our recognized scientific expertise is in the discovery and development of novel, selective small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. Click to learn more about our products in development.

GTx is a biopharmaceutical company dedicated to the discovery, development and commercialization of drug candidates. Click to learn more about the GTx management team.

GTx to Present Results on Enobosarm 9mg in Women with Metastatic Breast Cancer at 2014 San Antonio Breast Cancer Symposium

GTx Announces Closing of $43.4 Private Placement

GTx Announces Webcast of Corporate Presentation at the Stifel 2014 Healthcare Conference